Search Results - "Vuylsteke, Ronald J."
-
1
Feasibility of flowcytometric quantitation of immune effector cell subsets in the sentinel lymph node of the breast after cryopreservation
Published in Journal of immunological methods (31-01-2012)“…The sentinel lymph node (SLN) is an emerging focus for immunological research in breast cancer. Cryopreservation of SLN single-cell suspensions allows for…”
Get full text
Journal Article -
2
Breast cancer-induced immune suppression in the sentinel lymph node is effectively countered by CpG-B in conjunction with inhibition of the JAK2/STAT3 pathway
Published in Journal for immunotherapy of cancer (01-10-2020)“…BackgroundWe previously showed selectively hampered activation of lymph node-resident (LNR) dendritic cell (DC) subsets in the breast cancer (BrC) sentinel…”
Get full text
Journal Article -
3
Biological Mesh Closure of the Pelvic Floor After Extralevator Abdominoperineal Resection for Rectal Cancer: A Multicenter Randomized Controlled Trial (the BIOPEX-study)
Published in Annals of surgery (01-06-2017)“…To determine the effect of biological mesh closure on perineal wound healing after extralevator abdominoperineal resection (eAPR). Perineal wound complications…”
Get full text
Journal Article -
4
Local administration of granulocyte/macrophage colony-stimulating factor increases the number and activation state of dendritic cells in the sentinel lymph node of early-stage melanoma
Published in Cancer research (Chicago, Ill.) (15-11-2004)“…The initial tumor-draining lymph node, the sentinel lymph node, not only constitutes the first expected site of micrometastasis but also the first point of…”
Get full text
Journal Article -
5
In the mix: the potential benefits of adding GM-CSF to CpG-B in the local treatment of patients with early-stage melanoma
Published in Oncoimmunology (01-01-2020)“…Whereas TLR9 agonists are recognized as powerful stimulators of antitumor immunity, GM-CSF has had mixed reviews. In previously reported randomized trials we…”
Get full text
Journal Article -
6
Local Adjuvant Treatment with Low-Dose CpG-B Offers Durable Protection against Disease Recurrence in Clinical Stage I-II Melanoma: Data from Two Randomized Phase II Trials
Published in Clinical cancer research (01-10-2017)“…Although risk of recurrence after surgical removal of clinical stage I-II melanoma is considerable, there is no adjuvant therapy with proven efficacy. Here, we…”
Get full text
Journal Article -
7
Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study)
Published in Annals of surgery (01-01-2022)“…To determine long-term outcomes of a randomized trial (BIOPEX) comparing biological mesh and primary perineal closure in rectal cancer patients after…”
Get full text
Journal Article -
8
Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients
Published in World journal of surgery (01-12-2002)“…Studies of large series of melanoma patients indicated that the average incidence of developing a recurrence during follow‐up was 40%. The most frequent first…”
Get full text
Journal Article -
9
Unpredictability of lymphatic drainage patterns in melanoma patients
Published in European journal of nuclear medicine (01-02-2002)“…We analysed the localisations of sentinel nodes (SN) found with the SN procedure to compare these sites with those that would have been predicted by…”
Get full text
Journal Article -
10
Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node
Published in Journal for immunotherapy of cancer (22-05-2019)“…Immune regulated pathways influence both breast cancer (BrC) development and response to (neo)adjuvant chemotherapy. The sentinel lymph node (SLN), as the…”
Get full text
Journal Article -
11
Sentinel lymph node tumor load: an independent predictor of additional lymph node involvement and survival in melanoma
Published in Annals of surgical oncology (01-06-2005)“…Even though 60% to 80% of melanoma patients with a positive sentinel lymph node (SLN) have no positive additional lymph nodes (ALNs), all these patients are…”
Get full text
Journal Article -
12
Sampling Tumor-Draining Lymph Nodes for Phenotypic and Functional Analysis of Dendritic Cells and T Cells
Published in The American journal of pathology (01-07-2002)“…Immune responses against tumor antigens will initially occur in the first tumor-draining lymph node, the sentinel node (SN). Because of extensive diagnostic…”
Get full text
Journal Article -
13
The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma
Published in Cancer (15-06-2001)“…BACKGROUND In a cohort of patients, the authors investigated whether and to what extent the sentinel lymph node (SLN) status contributes to predicting the…”
Get full text
Journal Article -
14
Randomized controlled multicentre study comparing biological mesh closure of the pelvic floor with primary perineal wound closure after extralevator abdominoperineal resection for rectal cancer (BIOPEX-study)
Published in BMC surgery (27-08-2014)“…Primary perineal wound closure after conventional abdominoperineal resection (cAPR) for rectal cancer has been the standard of care for many years. Since the…”
Get full text
Journal Article -
15
Tumor-Specific CD8+ T Cell Reactivity in the Sentinel Lymph Node of GM-CSF–Treated Stage I Melanoma Patients is Associated with High Myeloid Dendritic Cell Content
Published in Clinical cancer research (01-05-2006)“…Purpose: Impaired immune functions in the sentinel lymph node (SLN) may facilitate early metastatic events during melanoma development. Local potentiation of…”
Get full text
Journal Article -
16
Matched Skin and Sentinel Lymph Node Samples of Melanoma Patients Reveal Exclusive Migration of Mature Dendritic Cells
Published in The American journal of pathology (01-11-2005)“…Mature and immature myeloid dendritic cells (DCs) are thought to differentially modulate T-cell responses in secondary lymphoid tissues. Although mature DCs…”
Get full text
Journal Article -
17
Preoperative granulocyte/macrophage colony-stimulating factor (GM-CSF) increases hepatic dendritic cell numbers and clustering with lymphocytes in colorectal cancer patients
Published in Immunobiology (1979) (01-01-2006)“…Despite surgery with curative intent, approximately 30% of colorectal carcinoma patients will develop liver metastases during follow-up. Synchronous occult…”
Get full text
Journal Article -
18
-
19
Optimised treatment of patients with enlarged lateral lymph nodes in rectal cancer: protocol of an international, multicentre, prospective registration study after extensive multidisciplinary training (LaNoReC)
Published in BMJ open (16-10-2024)“…IntroductionInadequate treatment of enlarged lateral lymph nodes (LLNs) in rectal cancer patients is associated with an increased lateral local recurrence…”
Get full text
Journal Article -
20
Abstract 4692: Local adjuvant treatment of clinical stage I-II melanoma with low dose CpG-B and/or GM-CSF: Long-term follow-up of three randomized controlled phase II trials
Published in Cancer research (Chicago, Ill.) (01-07-2017)“…Abstract Introduction: Currently, there is no widely used adjuvant treatment available to improve survival after surgical excision of localized melanoma. Here,…”
Get full text
Journal Article